Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOF Lipid for Acute Carbamazepine Poisoning
NCT06316362Phase 2Completed
- Sponsor
- Alexandria University
- Start
- Jan 2022
- Primary completion
- Feb 2023
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of SMOFlipid in carbamazepine poisoning, sponsored by Alexandria University. Started Jan 2022; status: completed.
02
Drugs
SMOFlipid
03
Conditions
carbamazepine poisoning
Beyond the preview
Go deeper on NCT06316362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06316362.